Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide
- J T Rosenbaum, MD, Oregon Health Sciences University, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97201, USA.
- Accepted 14 October 1996
Abstract
BACKGROUND Optic neuropathy is a rare manifestation of systemic lupus erythematosus (SLE). In a previous series most patients with optic neuropathy in association with SLE had a final visual acuity of 20/200 or less despite corticosteroid therapy.
METHODS Three patients (five affected eyes) with severe retrobulbar optic neuropathy in association with SLE were treated promptly with intravenous cyclophosphamide and corticosteroids.
RESULTS All patients recovered excellent visual acuity.
CONCLUSION Although optic neuropathy in association with SLE might have several different aetiologies, intravenous cyclophosphamide should be strongly considered as a therapeutic alternative.
